global view constructed of white lines

Blog

7 Questions About Alzheimer's Disease Cover Image
November 25, 2020

7 Common Questions about Alzheimer’s Disease

by Guest Author

Alzheimer’s disease is a neurodegenerative condition that affects thinking, behavior and social skills. Dr. Verna Porter, Director of the Dementia, Alzheimer’s Disease and Neurocognitive Disorders Program at Pacific Brain Health Center, talked about some everyday questions that people have with regard to this disease. 1....

Think Neuro Podcast The Promise of Psychedelics with Dr. Keith Heinzerling & Louie Schwartzberg
November 18, 2020

The Promise of Psychedelics | Dr. Keith Heinzerling & Louie Schwartzberg

by Anthony Effinger

The Think Neuro podcast from Pacific Neuroscience Institute takes you into the clinic, operating room and laboratory with doctors and surgeons who are tackling the most challenging brain diseases and disorders. Host: Anthony Effinger Subscribe: Google Podcasts | Apple Podcasts | Spotify | SimplecastWatch: YouTube Episode 9: Show Notes Addiction and depression are...

Kesimpta for Multiple Sclerosis
November 15, 2020

Multiple Sclerosis – A New Treatment, A New Hope

by Guest Author

A new self-administered drug for the treatment of Multiple Sclerosis has been approved by the US Food and Drug Administration (FDA). In a clinical trial, it outperformed an existing oral drug, with respect to decreasing relapses and new areas of nerve damage seen on MRI....

Learning an instrument during COVID
November 8, 2020

Optimizing Brain Health During COVID

by William Buxton

As physicians, we understand the tremendous value of cognitive, physical, and social activity in optimizing and preserving our abilities as we age. At first glance, it is easy to see COVID as an obstacle. However, there are many ways we can emerge from this period sharper, stronger and more resilient.

November Clinical Trials at PNI
November 2, 2020

Clinical Trials Round-Up: November 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Last updated: November 17th, 2020